Search Results for 'EPAX AS'
Refine by Dates:
Refine By
Content Type
BlogBreaking News
Buyers Guide Companies
Classifieds
Columns
Consumer Trends
Editorials
Features
Health E-Insights
Industry Events
Industry News
Market Research
Monograph Center
Naturally Filtered
Online Exclusives
Patents
Peer-reviewed Research
People In The News
Products
Recent Certifications & Approvals
Suppliers Corner
Supplier Research
Supply Source
TrendSense
Webinars
Buyers Guide Categories
View All Categories >>
Article Results
Published March 2, 2012
Epax AS, Oslo, Norway, has appointed Ola Snøve as CEO, replacing Terje Bakken. Mr. Snøve previously served as an investment director at Aker ASA. He is a member of Epax’s board of directors and knows the company well. Mr. Sn&oslas… Read More »
Published October 10, 2011
The omega 3 lipids corporation previously formed by Trygg Pharma and former EPAX AS will be named EPAX AS. Former EPAX AS will become Epax Norway AS, a fully owned subsidiary and the key operating company of the EPAX group. The new CEO is Terje Bakke… Read More »
Published May 5, 2011
EPAX AS, Aalesund, Norway, has received this year's Friend of the Sea (FOS) Award in the omega 3 category. The recognition is largely the result of EPAX's commitment to source from approved, sustainable fisheries and its marketing and communi… Read More »
By Brenda Porter-Rockwell, Contributing Writer
Published May 2, 2011
Eye health ingredients come into focus. Read More »
By Rebecca Wright
Published December 1, 2010
Executives reflect on the past year in nutraceuticals and look ahead to what the future might bring. Read More »
Published October 19, 2010
Epax AS confirmed that its DHA-rich 1050 TG formula is currently being studied for its potential effect on metabolic syndrome and its associated conditions. BIOCLAIMS, a scientific program that supports European university researchers and is funded b… Read More »
Published October 1, 2010
Trygg Pharma AS, a company jointly owned by Norwegian biotechnology company Aker BioMarine ASA and New York-based investment fund Lindsay Goldberg, has acquired omega 3 supplier EPAX AS from Austevoll Seafood ASA. As part of the agreement, EPAX has e… Read More »
Published September 3, 2010
Trygg Pharma AS, a company jointly owned by Norwegian biotechnology company Aker BioMarine ASA and New York-based investment fund Lindsay Goldberg, has acquired omega 3 supplier EPAX AS from Austevoll Seafood ASA. Read More »
By Sean Moloughney
Published September 1, 2010
Scientific strides have given the omega 3 market strong legs, but some significant hurdles still stand in the way. Read More »
Published October 1, 2009
Epax AS, Aalesund, Norway, has hired André Markussen as an additional North American sales manager. He has extensive experience in sales and marketing in the pharmaceutical area, previously serving as sales and marketing manager at Navamedic A… Read More »
Published May 1, 2009
The Austral Group, a sister subsidiary in the Austevoll fisheries group and supplier of omega 3 crude fish oil to EPAX AS, Aalesund, Norway, has received approval from the Institute of Fisheries Technology of Peru for its fish oil plants and fishing… Read More »
By Marian Zboraj
Published November 1, 2007
Exploring the trends and issues occurring in the marine nutraceuticals market. Read More »
Published October 1, 2007
Various companies involved in the supply of omega 3-based ingredients share their perspectives on recent developments, trade issues and new products. Read More »
By Marian Zboraj
Published June 1, 2007
In the intense search for ways to preserve brain health, consumers are turning to various ingredients aimed at maintaining or improving cognitive function. Read More »
By NW Staff
Published April 1, 2007
A listing of suppliers of joint health ingredients that can help alleviate health issues such as arthritis. Read More »
